|
EW | Edwards Lifesciences Corp |
|
|
EW | Edwards Lifesciences Corp |
| Orthopedic, Prosthetic & Surgical Appliances & Supplies |
| Book value per $ invested | $ 0.56 |
| Leverage | 23.86% |
| Market Cap | $ 54.9B |
| PE | 50.14 |
| Dividend Yield | 0.00% |
| Profit | $ 1.1B |
| Margin | 17.21% |
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.